[-] Show simple item record

dc.contributor.authorDiehr, Sabinaeng
dc.contributor.authorScoville, Caryneng
dc.date.issued2003-07eng
dc.description.abstractDesmopressin reduces the number of nights of primary noctural enuresis by at least 1 per week, and increases the likelihood of "cure" (defined as 14 consecutive dry nights) while treatment is continued (number needed to treat [NNT]=5-6) (strength of recommendation [SOR]: A, based on meta-analysis). Evidence suggests that the benefits of desmopressin are temporary, with a high relapse rate once treatment is discontinued (SOR: B). However, long-term therapy with occasional weaning attempts is a safe option (SOR: B). Evidence is inadequate to judge the relative efficacy of the nasal vs oral forms of desmopressin (SOR: C).eng
dc.identifier.citationJournal of Family Practice, 52(7) 2003: 568-569.eng
dc.identifier.urihttp://hdl.handle.net/10355/2941eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofClinical Inquiries, 2003 (MU)eng
dc.relation.ispartofcollectionUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjecturine productioneng
dc.subjectrelapse rateeng
dc.subjectpituitary hormoneeng
dc.subjectlong-term therapyeng
dc.subject.lcshUrologyeng
dc.subject.lcshGenitourinary organseng
dc.subject.lcshSleep disorderseng
dc.subject.meshUrination Disorderseng
dc.titleHow effective is desmopressin for primary nocturnal enuresis?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record